2798
A.V. Dubrovskiy, R.C. Larock / Tetrahedron 69 (2013) 2789e2798
17. See Katritzky, A. R.; Le, K. N. B.; Mohapatra, P. P. Synthesis 2007, 3141 and ref-
(150 MHz, CDCl3)
d 21.0, 21.7, 21.9, 28.2, 117.6, 118.4, 123.2, 124.4,
erences therein for the biological activity of o-hydroxyaryl ketones.
125.7, 132.9, 155.9, 163.9, 177.8; HRMS (APCI) calcd for [MþH]þ
C13H13O2 201.0910, found 201.0916. The 1H and 13C NMR spectral
data are in good agreement with the literature data.56
18. (a) Merza, J.; Aumond, M.-C.; Rondeau, D.; Dumontet, V.; Le Ray, A.-M.;
ꢀ
Seraphin, D.; Richomme, P. Phytochemistry 2004, 65, 2915; (b) Mors, W. B.;
Gottlieb, O. R.; Djerassi, C. J. Am. Chem. Soc. 1957, 79, 4507; (c) Nanda, B.; Pat-
wardhan, S. A.; Gupta, A. S. Indian J. Chem., Sect. B 1983, 22, 185.
19. Okuma, K.; Nojima, A.; Matsunaga, N.; Shioji, K. Org. Lett. 2009, 11, 169.
20. Wu, C.-P.; van Schalkwyk, D. A.; Taylor, D.; Smith, P. J.; Chibale, K. Int. J. Anti-
microb. Agents 2005, 26, 170.
4.5. Procedure for the preparation of methyl (E)-2-benzyl-3-
phenylacrylate (57)
21. Chibale, K.; Visser, M.; van Schalkwyk, D.; Smith, P. J.; Saravanamuthu, A.;
Fairlamb, A. H. Tetrahedron 2003, 59, 2289.
22. Burmester, J. K. U.S. Patent WO 2006102102, 2006.
23. Tadross, P. M.; Gilmore, C. D.; Bugga, P.; Virgil, S. C.; Stoltz, B. M. Org. Lett. 2010,
12, 1224.
o-(Trimethylsilyl)phenyl triflate (3.0 equiv) was added to
a mixture of methyl methacrylate (0.25 mmol) and CsF (6.0 equiv)
in 5 mL of MeCN, and the reaction mixture was stirred at room
temperature for 18 h. The reaction mixture was then eluted through
a plug of silica gel with ethyl acetate and the solvent was removed
under reduced pressure. The residue was purified by flash chro-
matography on silica gel using hexanes/EtOAc as the eluent to af-
ford the desired diarylated product 57 as a colorless oil in an 80%
24. Joshi, B. S.; Ravindranath, K. W. J. Chem. Soc., Perkin Trans. 1 1977, 433.
25. (a) Na, Y. J. Pharm. Pharmacol. 2009, 61, 707; (b) El-Seedi, H. R.; El-Ghorab, D. M.
H.; El-Barbary, M. A.; Zayed, M. F.; Goeransson, U.; Larsson, S.; Verpoorte, R.
Curr. Med. Chem. 2009, 16, 2581; (c) Diderot, N. T.; Silvere, N.; Etienne, T. Adv.
Phytomed. 2006, 2, 273.
26. Examples of Heck and SuzukieMiyaura coupling processes for 2-bromoxanthone
have been demonstrated by the Larock group in: Zhao, Z.; Larock, R. C. J. Org. Chem.
2007, 72, 583.
27. (a) Jeganmohan, M.; Bhuvaneswari, S.; Cheng, C.-H. Chem.dAsian J. 2010, 5, 153;
(b) Rogness, D. C.; Markina, N. A.; Waldo, J. P.; Larock, R. C. J. Org. Chem. 2012, 77,
2743.
28. Pedro, M.; Cerqueira, F.; Sousa, M. E.; Nascimento, M. S. J.; Pinto, M. Bioorg. Med.
Chem. 2002, 10, 3725.
yield: 1H NMR (400 MHz, CDCl3)
7.17e7.41 (m, 10H), 7.95 (s, 1H); 13C NMR (100 MHz, CDCl3)
d
3.76 (s, 3H), 3.97 (s, 2H),
33.4,
d
52.3, 126.3, 128.1, 128.7, 128.8, 129.0, 129.4, 130.9, 135.6, 139.6, 141.2,
168.8; HRMS (EI) calcd for C17H16O2 252.1150, found 252.1170. The
1H and 13C NMR spectral data are in good agreement with the lit-
erature data.43b
29. See: Peres, V.; Nagem, T. J.; de Oliveira, F. F. Phytochemistry 2000, 55, 683 and
references therein.
30. Chen, C.-H.; Lin, J.-Y.; Lin, C.-N.; Hsu, S.-Y. J. Nat. Prod. 1992, 55, 691.
31. Wang, J.-P.; Raung, S.-L.; Lin, C.-N.; Teng, C.-M. Eur. J. Pharmacol. 1994, 251, 35.
32. Gnerre, C.; Thull, U.; Gaillard, P.; Carrupt, P.-A.; Testa, B.; Fernandes, E.; Silva, F.;
Pinto, M.; Pinto, M. M. M.; Wolfender, J.-L.; Hostettmann, K.; Cruciani, G. Helv.
Chim. Acta 2001, 84, 552.
Acknowledgements
We thank the National Science Foundation, the National In-
stitute of General Medical Sciences (GM079593) and the National
Institutes of Health Kansas University Center of Excellence in
Chemical Methodology and Library Development (P50 GM069663)
for their generous financial support. We also thank Dr. Feng Shi,
while at Iowa State University, for the preparation of some aryne
precursors.
33. For similar reactivity of 3-methoxybenzyne, see: Dubrovskiy, A. V.; Larock, R. C.
Org. Lett. 2010, 12, 1180.
34. (a) Brahmachari, G. Nat. Prod. Commun. 2008, 3, 1337; (b) Horton, D. A.; Bourne,
G. T.; Smythe, M. L. Chem. Rev. 2003, 103, 893; (c) Birt, D. F.; Hendrich, S.; Wang,
W. Pharmacol. Ther. 2001, 90, 157; (d) Kim, H. P.; Son, K. H.; Chang, H. W.; Kang,
S. S. J. Pharm. Sci. 2004, 96, 229.
35. Running the reaction with TBAT in THF ensures the complete conversion of the
acid, but also results in higher yields of undesired overarylated products
(analogous to products 5 and 6).
36. Apparently, an excess of the benzyne intermediate is more likely to engage in
the reaction with the phenoxide formed as a result of the opening of a four-
membered ring in an intermediate like 9, rather than with the starting, less
reactive carboxylic acid. Ideally, the slow addition technique could be beneficial
to the yield of the reaction. However, running the reaction in an overheated
solvent in a pressurized vial makes this hypothesis difficult to test.
37. Tanaka, K.; Sugino, T. Green Chem. 2001, 3, 133.
Supplementary data
Supplementary data related to this article can be found at http://
38. The only detected by-product was the O-monoarylation product.
39. Bowers, W.; Ohta, T.; Cleere, J.; Marsella, P. Science 1976, 193, 542.
40. Rao, Y. K.; Fang, S.-H.; Tzeng, Y.-M. J. Ethnopharmacol. 2005, 100, 249.
41. Le Bail, J.-C.; Aubourg, L.; Habrioux, G. Cancer Lett. 2000, 156, 37.
42. Martin, R. Org. Prep. Proced. Int. 1992, 24, 369.
References and notes
1. Liu, Z.; Larock, R. C. J. Am. Chem. Soc. 2005, 127, 13112.
2. Pintori, D. G.; Greaney, M. F. Org. Lett. 2010, 12, 168.
43. (a) Navarre, L.; Darses, S.; Genet, J.-P. Adv. Synth. Catal. 2006, 348, 317; (b)
Kantam, M. L.; Kumar, K. B. S.; Sreedhar, B. J. Org. Chem. 2008, 73, 320.
44. Canter, F. W.; Curd, F. H.; Robertson, A. J. Chem. Soc. 1931, 1245.
45. Dhar, S. N. J. Chem. Soc. 1920, 117, 1053.
46. Wang, Z.; Zhou, L.-J.; Wang, Y.-L.; Weng, Y.-B.; He, J.; Nie, K. J. Chem. Res. 2011,
35, 373.
3. Tambar, U. K.; Stoltz, B. M. J. Am. Chem. Soc. 2005, 127, 5340.
4. Sato, Y.; Kobayashi, Y.; Sugiura, M.; Shirai, H. J. Org. Chem. 1978, 43, 199.
5. Yoshida, H.; Honda, Y.; Shirakawa, E.; Hiyama, T. Chem. Commun. 2001, 1880.
6. Yoshida, H.; Mimura, Y.; Ohshita, J.; Kunai, A. Chem. Commun. 2007, 2405.
7. Yoshida, H.; Watanabe, M.; Fukushima, H.; Ohshita, J.; Kunai, A. Org. Lett. 2004,
6, 4049.
47. Zhao, J.; Yue, D.; Campo, M. A.; Larock, R. C. J. Am. Chem. Soc. 2007, 129, 5288.
48. Gindy, M. Nature 1949, 164, 577.
49. Hassall, C. H.; Lewis, J. R. J. Chem. Soc. 1961, 2312.
50. Ueda, S.; Kurosawa, K. Bull. Chem. Soc. Jpn. 1977, 50, 193.
51. Hu, H.; Liao, H.; Zhang, J.; Wu, W.; Yan, J.; Yan, Y.; Zhao, Q.; Zou, Y.; Chai, X.; Yu,
S.; Wu, Q. Bioorg. Med. Chem. Lett. 2010, 20, 3094.
8. Liu, Z.; Larock, R. C. Org. Lett. 2004, 6, 99.
9. Dubrovskiy, A. V.; Larock, R. C. Org. Lett. 2010, 12, 3117.
10. Chai, G.; Qiu, Y.; Fu, C.; Ma, S. Org. Lett. 2011, 13, 5196.
11. Himeshima, Y.; Sonoda, T.; Kobayashi, H. Chem. Lett. 1983, 1211.
12. Slana, G. B. C. A.; Azevedo, M. S. de; Lopes, R. S. C.; Lopes, C. C.; Cardoso, J. N.
Beilstein J. Org. Chem. 2006, 2, 1.
52. Biddle, M. M.; Lin, M.; Scheidt, K. A. J. Am. Chem. Soc. 2007, 129, 3830.
53. Yenjai, C.; Wanich, S. Bioorg. Med. Chem. Lett. 2010, 20, 2821.
54. Okuma, K.; Matsunaga, N.; Nagahora, N.; Shioji, K.; Yokomori, Y. Chem. Com-
mun. 2011, 5822.
55. Watanabe, T.; Katayama, S.; Nakashita, Y.; Yamauchi, M. Chem. Pharm. Bull. 1977,
25, 2778.
13. For a related transformation, see: Zhao, J.; Larock, R. C. J. Org. Chem. 2007, 72,
583 See the supplementary data for spectral evidence for the formation of 5.
14. Kotali, A.; Harris, P. A. Org. Prep. Proced. Int. 1994, 26, 159.
15. (a) Zhang, L.; Zhang, J. Y. J. Comb. Chem. 2006, 8, 361; (b) Piccolo, O.; Filippini, L.;
Tinucci, L.; Valoti, E.; Citterio, A. Tetrahedron 1986, 42, 885.
16. Rozenberg, V.; Danilova, T.; Sergeeva, E.; Vorontsov, E.; Starikova, Z.; Lysenko,
K.; Belokon’, Y. Eur. J. Org. Chem. 2000, 3295.
56. Turner, P. A.; Griffin, E. M.; Whatmore, J. L.; Shipman, M. Org. Lett. 2011, 13, 1056.